GB201908441D0 - Antisense oligonucleotides for immunotherapy - Google Patents
Antisense oligonucleotides for immunotherapyInfo
- Publication number
- GB201908441D0 GB201908441D0 GBGB1908441.7A GB201908441A GB201908441D0 GB 201908441 D0 GB201908441 D0 GB 201908441D0 GB 201908441 A GB201908441 A GB 201908441A GB 201908441 D0 GB201908441 D0 GB 201908441D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- immunotherapy
- antisense oligonucleotides
- antisense
- oligonucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1908441.7A GB201908441D0 (en) | 2019-06-12 | 2019-06-12 | Antisense oligonucleotides for immunotherapy |
CA3132178A CA3132178A1 (en) | 2019-04-02 | 2020-03-27 | Antisense oligonucleotides for immunotherapy |
PCT/EP2020/058828 WO2020201144A1 (en) | 2019-04-02 | 2020-03-27 | Antisense oligonucleotides for immunotherapy |
US17/442,913 US20220177894A1 (en) | 2019-04-02 | 2020-03-27 | Antisense oligonucleotides for immunotherapy |
AU2020254929A AU2020254929A1 (en) | 2019-04-02 | 2020-03-27 | Antisense oligonucleotides for immunotherapy |
EP20719120.6A EP3947678A1 (en) | 2019-04-02 | 2020-03-27 | Antisense oligonucleotides for immunotherapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1908441.7A GB201908441D0 (en) | 2019-06-12 | 2019-06-12 | Antisense oligonucleotides for immunotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201908441D0 true GB201908441D0 (en) | 2019-07-24 |
Family
ID=67386360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1908441.7A Ceased GB201908441D0 (en) | 2019-04-02 | 2019-06-12 | Antisense oligonucleotides for immunotherapy |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201908441D0 (en) |
-
2019
- 2019-06-12 GB GBGB1908441.7A patent/GB201908441D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL286487A (en) | Technologies useful for oligonucleotide preparation | |
SG11202102710SA (en) | Nuclease-based rna depletion | |
SG11202000276YA (en) | Technologies for oligonucleotide preparation | |
GB202018087D0 (en) | No details | |
GB202013426D0 (en) | No Details | |
GB201711809D0 (en) | Antisense oligonucleotide | |
IL285307A (en) | Combination gene targets for improved immunotherapy | |
GB202009212D0 (en) | No details | |
GB201904709D0 (en) | Chemically modified oligonucleotides | |
CA189818S (en) | Handshower holder | |
GB202017837D0 (en) | No details | |
EP3449002A4 (en) | G-quadruplex-containing antisense oligonucleotides | |
GB201904887D0 (en) | Lifebit al | |
EP3532617A4 (en) | Antisense oligonucleotides | |
GB202015405D0 (en) | No details | |
GB201903229D0 (en) | Immunotherapy | |
EP3999523A4 (en) | Melanophilin antisense oligonucleotides | |
EP4041248A4 (en) | Modified oligonucleotides | |
GB201909538D0 (en) | Deposition apparatus | |
GB202014354D0 (en) | No details | |
EP3638253A4 (en) | Methods for treating multiple sclerosis using antisense oligonucleotides | |
EP3697910A4 (en) | Antisense oligomer compounds | |
GB201908441D0 (en) | Antisense oligonucleotides for immunotherapy | |
GB201904647D0 (en) | Antisense oligonucleotides for immunotherapy | |
EP3837274A4 (en) | Acetyl-coa carboxylase2 antisense oligonucleotides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |